NEVRO CORP
DelistedCIK 1444380fmd_01CM0EEJTTP6MD4GM9AV11XJ8JManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2024, 49 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 70 | 229 | 327 | 387 | 390 | 362 | 387 | 406 | 425 | 409 |
| Cost of revenue | 28 | 75 | 99 | 114 | 122 | 112 | 121 | 130 | 135 | 139 |
| Net interest income | – | – | – | – | – | – | – | – | – | – |
| Gross profit | 41 | 153 | 228 | 273 | 268 | 250 | 266 | 276 | 290 | 270 |
| Realized investment gains (losses) | 0 | 0 | – | – | – | – | – | – | – | – |
| Research and development | 21 | 34 | 38 | 48 | 59 | 46 | 48 | 53 | 54 | 52 |
| Selling, general and administrative | 82 | 142 | 220 | 267 | 306 | 267 | 309 | 322 | 335 | 310 |
| Total operating expenses | 104 | 176 | 257 | 315 | 365 | 313 | 377 | 270 | 389 | 396 |
| Operating income | (62) | (23) | (30) | (42) | (96) | (63) | (111) | 6 | (99) | (126) |
| Interest expense | 3 | 6 | 10 | 10 | 11 | 22 | 20 | 6 | 8 | 27 |
| Interest and investment income | 1 | 2 | 3 | 5 | 6 | 3 | 1 | 4 | 14 | 13 |
| Other non-operating income (expense) | (2) | (1) | 1 | (1) | (1) | (0) | (1) | 1 | (1) | (0) |
| Income before taxes | (66) | (30) | (35) | (48) | (102) | (82) | (131) | 4 | (98) | (112) |
| Income tax expense | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | (6) | 1 |
| Net income from continuing operations | (67) | (32) | (37) | (49) | (104) | (83) | (131) | 3 | (92) | (113) |
| Net income | (67) | (32) | (37) | (49) | (104) | (83) | (131) | 3 | (92) | (113) |
| Net income to common shareholders | (67) | (32) | – | – | – | (83) | (131) | 3 | (92) | (113) |